AQP4 and myeloid sarcoma: MOGAD has a female-to-male ratio of approximately 1:1, which differs from the female predominance typically observed in other autoimmune or immune-mediated disorders, including AQP4 Ab+ NMOSD (9:1) and MS (3:1) [1].